{
    "xml": "<topic id=\"PHP95883\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/twinrix-adult\" basename=\"twinrix-adult\" title=\"Twinrix Adult\">\n<title>Twinrix<tm tmtype=\"reg\"/> Adult</title>\n<topic id=\"PHP96247\" outputclass=\"indicationsAndDose\" rev=\"1.53\" parent=\"/clinical-medicinal-product-information/twinrix-adult\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A and hepatitis B infection</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 16&#8211;17 years</p>\n<p>Initially 1&#8239;mL every 1&#8239;month for 2 doses, then 1&#8239;mL after 5&#8239;months for 1 dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 1&#8239;mL every 1&#8239;month for 2 doses, then 1&#8239;mL after 5&#8239;months for 1 dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A and hepatitis B infection (accelerated schedule for travellers departing within 1 month)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 16&#8211;17 years</p>\n<p>Initially 1&#8239;mL for 1 dose, then 1&#8239;mL after 7&#8239;days for 1 dose, then 1&#8239;mL after 14&#8239;days for 1 dose, then 1&#8239;mL for 1 dose given 12 months after the first dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 1&#8239;mL for 1 dose, then 1&#8239;mL after 7&#8239;days for 1 dose, then 1&#8239;mL after 14&#8239;days for 1 dose, then 1&#8239;mL for 1 dose given 12 months after the first dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP96296\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/clinical-medicinal-product-information/twinrix-adult\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Primary course should be completed with <i>Twinrix</i>\n<tm tmtype=\"reg\"/> (single component vaccines given at appropriate intervals may be used for booster dose).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP95883",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/twinrix-adult",
    "basename": "twinrix-adult",
    "title": "Twinrix Adult",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Immunisation against hepatitis A and hepatitis B infection",
                        "html": "Immunisation against hepatitis A and hepatitis B infection"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection"
                    ],
                    "textContent": "By intramuscular injection",
                    "html": "By intramuscular injection"
                },
                "child": [
                    {
                        "textContent": "Initially 1 mL every 1 month for 2 doses, then 1 mL after 5 months for 1 dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).",
                        "html": "<p>Initially 1&#8239;mL every 1&#8239;month for 2 doses, then 1&#8239;mL after 5&#8239;months for 1 dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>",
                        "ageGroup": "16&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 1 mL every 1 month for 2 doses, then 1 mL after 5 months for 1 dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).",
                        "html": "<p>Initially 1&#8239;mL every 1&#8239;month for 2 doses, then 1&#8239;mL after 5&#8239;months for 1 dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Immunisation against hepatitis A and hepatitis B infection (accelerated schedule for travellers departing within 1 month)",
                        "html": "Immunisation against hepatitis A and hepatitis B infection (accelerated schedule for travellers departing within 1 month)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection"
                    ],
                    "textContent": "By intramuscular injection",
                    "html": "By intramuscular injection"
                },
                "child": [
                    {
                        "textContent": "Initially 1 mL for 1 dose, then 1 mL after 7 days for 1 dose, then 1 mL after 14 days for 1 dose, then 1 mL for 1 dose given 12 months after the first dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).",
                        "html": "<p>Initially 1&#8239;mL for 1 dose, then 1&#8239;mL after 7&#8239;days for 1 dose, then 1&#8239;mL after 14&#8239;days for 1 dose, then 1&#8239;mL for 1 dose given 12 months after the first dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>",
                        "ageGroup": "16&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 1 mL for 1 dose, then 1 mL after 7 days for 1 dose, then 1 mL after 14 days for 1 dose, then 1 mL for 1 dose given 12 months after the first dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).",
                        "html": "<p>Initially 1&#8239;mL for 1 dose, then 1&#8239;mL after 7&#8239;days for 1 dose, then 1&#8239;mL after 14&#8239;days for 1 dose, then 1&#8239;mL for 1 dose given 12 months after the first dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>"
                    }
                ]
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Primary course should be completed with Twinrix (single component vaccines given at appropriate intervals may be used for booster dose).",
                "html": "<p>Primary course should be completed with <i>Twinrix</i>\n<tm tmtype=\"reg\"/> (single component vaccines given at appropriate intervals may be used for booster dose).</p>"
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}